Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Conditions: Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute Intervention: Biological: CD123 CAR-T cells Sponsor: Chongqing Precision Biotech Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials